There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
19544.25 Cr.Face value
2.00Book value
332.64Div. yield
0.41%P/E ratio
97.29P/B ratio
0.00Debt/Eq.
-Market Cap
19544.25 Cr.Face value
2.00Book value
332.64Div. yield
0.41%P/E ratio
97.29P/B ratio
0.00Debt/Eq.
-
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 75.00% | 75.00% | 0.00% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
AstraZeneca Pharma India (AZPIL), incorporated on July 11, 1979, is a global, science-led, patient-focused pharmaceutical company. The company is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca P Read more 
It manufactures, distributes and markets pharmaceutical products in India and provides clinical trial services to an overseas group company .
The company focuses on Oncology, Biopharmaceuticals (CVRM; R&I) and Rare Disease, reflecting the parent group’s global priorities .
